\n
\u00c7ALI\u015eMA ve Sosyal G\u00fcvenlik Bakan\u0131 Vedat I\u015f\u0131khan, “27 Ocak 2026 tarihi itibar\u0131yla geri \u00f6deme listelerinde bulunan ila\u00e7 say\u0131s\u0131 8 bin 913’e ula\u015fm\u0131\u015ft\u0131r; bunlar\u0131n 919’u kanser, 53’\u00fc MS tedavisinde kullan\u0131lan ila\u00e7lard\u0131r” dedi.<\/p>\n
Bakan I\u015f\u0131khan, Ankara’da, Sosyal G\u00fcvenlik Kurumu (SGK), Sa\u011fl\u0131k Bilimleri \u00dcniversitesi, Ankara \u00dcniversitesi ve T\u00fcrkiye Sa\u011fl\u0131k Enstit\u00fcleri Ba\u015fkanl\u0131\u011f\u0131 aras\u0131nda haz\u0131rlanan ‘Sa\u011fl\u0131k Politikalar\u0131 ve Finansman\u0131 \u0130\u015f Birli\u011fi Protokol\u00fc \u0130mza T\u00f6reni’ne kat\u0131ld\u0131. SGK binas\u0131nda d\u00fczenlenen t\u00f6rende konu\u015fan Bakan I\u015f\u0131khan, “15 Ocak 2025 tarihli Resmi Gazete’de yay\u0131mlanan 7538 say\u0131l\u0131 Kanun ile muayene kat\u0131l\u0131m pay\u0131 tutarlar\u0131nda d\u00fczenleme yap\u0131lm\u0131\u015ft\u0131r. Bununla birlikte sa\u011fl\u0131k hizmetine eri\u015fimi kolayla\u015ft\u0131ran yap\u0131sal ad\u0131mlar at\u0131lm\u0131\u015f; bir\u00e7ok bran\u015fta uzman hekimlerce re\u00e7ete edilebilen ila\u00e7lar\u0131n aile hekimlerince de re\u00e7ete edilebilmesi sa\u011flanm\u0131\u015ft\u0131r. B\u00f6ylelikle hastanelere ba\u015fvurmadan, aile hekimlerine yazd\u0131r\u0131labilecek ila\u00e7 say\u0131s\u0131 6 bine, aile hekimi ve uzman hekimlerce rapor d\u00fczenlenen ila\u00e7 say\u0131s\u0131 ise 2 bin 730’a \u00e7\u0131kar\u0131lm\u0131\u015ft\u0131r. Sosyal G\u00fcvenlik Kurumumuz ile T\u00fcrk Eczac\u0131lar\u0131 Birli\u011fi aras\u0131nda 1 Ekim 2024 tarihinden itibaren y\u00fcr\u00fcrl\u00fc\u011fe girmek \u00fczere imzalanan protokol ile vatanda\u015flar\u0131m\u0131z\u0131n eczanelerden ila\u00e7 teminine ili\u015fkin s\u00fcre\u00e7ler g\u00fcvence alt\u0131na al\u0131nm\u0131\u015ft\u0131r. Ayr\u0131ca 31 Aral\u0131k 2025 tarihinde, 1 Ocak 2026’dan ge\u00e7erli olmak \u00fczere yeni bir protokol daha imzalanarak s\u00fcre\u00e7lerin kesintisiz devam\u0131 sa\u011flanm\u0131\u015ft\u0131r” ifadelerini kulland\u0131.<\/p>\n
‘KANSERLE M\u00dcCADELEDE \u00d6NEML\u0130 B\u0130R E\u015e\u0130K A\u015eILMI\u015eTIR’<\/p>\n
Bakan I\u015f\u0131khan, geri \u00f6deme listesine al\u0131nan ila\u00e7lar hakk\u0131nda da, “SMA tedavisinde 2017 y\u0131l\u0131ndan bu yana geri \u00f6demesi yap\u0131lan ilaca ilave olarak, kullan\u0131m kolayl\u0131\u011f\u0131 sa\u011flayan bir ba\u015fka ila\u00e7 da geri \u00f6deme listesine al\u0131nm\u0131\u015f; oral tedavi se\u00e7ene\u011fi kullanacak hastalar\u0131m\u0131za alternatif eri\u015fim imkan\u0131 sunulmu\u015ftur. Hemofili A hastalar\u0131nda evde deri alt\u0131na uygulanabilen kanama \u00f6nleyici tedavi geri \u00f6deme kapsam\u0131na al\u0131nm\u0131\u015f; b\u00f6ylelikle \u00e7ocuklar\u0131m\u0131z ve aileleri i\u00e7in tedavi s\u00fcreci b\u00fcy\u00fck \u00f6l\u00e7\u00fcde kolayla\u015ft\u0131r\u0131lm\u0131\u015ft\u0131r. Kanserle m\u00fccadelede de \u00f6nemli bir e\u015fik a\u015f\u0131lm\u0131\u015ft\u0131r. Kamuoyuna kanser ila\u00e7lar\u0131 olarak bilinen 5 farkl\u0131 imm\u00fcnoterapi ilac\u0131, Temmuz 2025’ten itibaren 25 farkl\u0131 kanser t\u00fcr\u00fcnde geri \u00f6deme kapsam\u0131na al\u0131nm\u0131\u015ft\u0131r. Son 6 ayda 22 bin kanser hastas\u0131 vatanda\u015f\u0131m\u0131za bu kanser ila\u00e7lar\u0131 sa\u011flanm\u0131\u015ft\u0131r. 31 Aral\u0131k 2025 itibar\u0131yla geri \u00f6deme listelerinde 96’s\u0131 yurt d\u0131\u015f\u0131ndan \u015fahsi tedavi i\u00e7in tedarik edilen, 820’si \u00fclkemizde ruhsatl\u0131 olmak \u00fczere toplam 916 kanser ilac\u0131 yer almaktad\u0131r. 27 Ocak 2026 tarihi itibar\u0131yla geri \u00f6deme listelerinde bulunan ila\u00e7 say\u0131s\u0131 8 bin 913’e ula\u015fm\u0131\u015ft\u0131r; bunlar\u0131n 919’u kanser, 53’\u00fc MS tedavisinde kullan\u0131lan ila\u00e7lard\u0131r. Kistik fibrozis hastal\u0131\u011f\u0131nda ya\u015fam kalitesini art\u0131ran ila\u00e7 geri \u00f6deme kapsam\u0131na al\u0131nm\u0131\u015f; nadir hastal\u0131klarda kullan\u0131lan ila\u00e7lara biyo-benzer alternatifler i\u00e7in geri \u00f6deme modelleri uygulanm\u0131\u015ft\u0131r. Fabry hastal\u0131\u011f\u0131nda enzim replasman tedavisine alternatif olarak oral kullan\u0131m imkan\u0131 sunan ila\u00e7 da geri \u00f6deme kapsam\u0131na dahil edilmi\u015ftir. Yo\u011fun bak\u0131mlarda olu\u015fturulan sa\u011fl\u0131k verilerinin e-Nab\u0131z sistemine aktar\u0131lmas\u0131 sa\u011flanarak hastalar\u0131n yo\u011fun bak\u0131m verilerinin anl\u0131k takibi m\u00fcmk\u00fcn hale getirilmi\u015ftir. Uyu\u015fturucu ile M\u00fccadele Ulusal Strateji Belgesi kapsam\u0131nda \u00c7ok Disiplinli \u00c7ocuk ve Gen\u00e7 Ruh Sa\u011fl\u0131\u011f\u0131 Merkezleri hizmetleri geri \u00f6demeye al\u0131nm\u0131\u015ft\u0131r” diye konu\u015ftu.<\/p>\n
‘2025’TE 474 \u0130LA\u00c7 GER\u0130 \u00d6DEME L\u0130STES\u0130NE EKLEND\u0130’<\/p>\n
I\u015f\u0131khan kontrast madde ile \u00e7ekilen MR ve BT i\u015flemlerinde, daha \u00f6nce vatanda\u015flar\u0131n eczaneden temin ederek hastaneye getirdi\u011fi ila\u00e7lar\u0131n art\u0131k hastaneler taraf\u0131ndan temin edildi\u011fini hat\u0131rlatarak, “2025 y\u0131l\u0131 aral\u0131k ay\u0131nda yap\u0131lan SUT d\u00fczenlemesi ile ayakta ve yatarak tedavi bedellerinde y\u00fczde 30, yo\u011fun bak\u0131m tedavi bedellerinde y\u00fczde 55, do\u011fum bedellerinde y\u00fczde 30, fizik tedavi ve rehabilitasyon bedellerinde y\u00fczde 30, palyatif bak\u0131m tedavi bedellerinde y\u00fczde 40, diyaliz ve kan \u00fcr\u00fcnleri bedellerinde y\u00fczde 35, laboratuvar ve g\u00f6r\u00fcnt\u00fcleme bedellerinde y\u00fczde 10, di\u015f tedavi bedellerinde y\u00fczde 20 oran\u0131nda art\u0131\u015f sa\u011flanm\u0131\u015ft\u0131r. Yatarak tedavilerde kullan\u0131lan t\u0131bbi malzemelerde ise y\u00fczde 10 ila y\u00fczde 85 aras\u0131nda art\u0131\u015f yap\u0131lm\u0131\u015ft\u0131r. 2026 y\u0131l\u0131 ocak ay\u0131nda yap\u0131lan d\u00fczenleme ile acil serviste k\u0131rm\u0131z\u0131 alanda uygulanan i\u015flem bedellerinde y\u00fczde 54, yenido\u011fan ve \u00e7ocuk cerrahisi i\u015flem bedellerinde y\u00fczde 54 ila y\u00fczde 67, kemoterapi uygulamalar\u0131nda y\u00fczde 54, hiperbarik oksijen tedavisinde y\u00fczde 4 oran\u0131nda art\u0131\u015f ger\u00e7ekle\u015ftirilmi\u015ftir. Ayr\u0131ca hasta alt bezi, tekerlekli sandalye, i\u015fitme cihaz\u0131, uyku ve solunum cihazlar\u0131 ile diyabet tedavisinde kullan\u0131lan t\u0131bbi malzemelerin fiyatlar\u0131nda y\u00fczde 20 oran\u0131nda art\u0131\u015f yap\u0131lm\u0131\u015ft\u0131r. 1 Ocak 2025 – 31 Aral\u0131k 2025 tarihleri aras\u0131nda toplam 474 ila\u00e7 geri \u00f6deme listesine eklenmi\u015f; bunlar\u0131n 69’u kanser tedavisinde kullan\u0131lan ila\u00e7lard\u0131r. B\u00fct\u00fcn bu ad\u0131mlar, sa\u011fl\u0131k hizmetlerinin etkinli\u011fini art\u0131rmak, vatanda\u015flar\u0131m\u0131z\u0131n ilaca ve tedaviye eri\u015fimini kolayla\u015ft\u0131rmak ve sa\u011fl\u0131k finansman yap\u0131s\u0131n\u0131 dengeli bi\u00e7imde s\u00fcrd\u00fcrmek amac\u0131yla hayata ge\u00e7irilmi\u015ftir. Sosyal G\u00fcvenlik Kurumumuz, g\u00fc\u00e7l\u00fc altyap\u0131s\u0131 ve kararl\u0131 uygulamalar\u0131yla Genel Sa\u011fl\u0131k Sigortas\u0131 sistemini daha eri\u015filebilir, daha kapsay\u0131c\u0131 ve daha s\u00fcrd\u00fcr\u00fclebilir bir yap\u0131ya kavu\u015fturma iradesini kararl\u0131l\u0131kla s\u00fcrd\u00fcrmektedir. G\u00fcn\u00fcm\u00fczde, toplumun sa\u011fl\u0131kl\u0131 bireylerden olu\u015fmas\u0131 ve bunun devam\u0131n\u0131n sa\u011flanmas\u0131 ekonomik kalk\u0131nma a\u00e7\u0131s\u0131ndan \u00f6nemli bir g\u00f6sterge olarak kabul edilmektedir” dedi. <\/p>\n
Bakan I\u015f\u0131khan’\u0131n konu\u015fmas\u0131n\u0131n ard\u0131ndan ilgili kurumlar aras\u0131nda protokol imzaland\u0131. <\/p>\n","protected":false},"excerpt":{"rendered":"
Bakan I\u015f\u0131khan, geri \u00f6deme listesinde bulunan ila\u00e7 say\u0131s\u0131n\u0131 8,913’e \u00e7\u0131kard\u0131klar\u0131n\u0131 a\u00e7\u0131klad\u0131.<\/p>\n","protected":false},"author":1,"featured_media":43384,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[12],"tags":[5922,467,660,571,577],"class_list":["post-43383","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-siyaset","tag-geri-odeme","tag-hasta","tag-ilac","tag-kanser","tag-tedavi"],"_links":{"self":[{"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/posts\/43383","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/comments?post=43383"}],"version-history":[{"count":1,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/posts\/43383\/revisions"}],"predecessor-version":[{"id":43385,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/posts\/43383\/revisions\/43385"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/media\/43384"}],"wp:attachment":[{"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/media?parent=43383"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/categories?post=43383"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bihavadis.com\/index.php\/wp-json\/wp\/v2\/tags?post=43383"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}